Prescription Eye Dropsfor Myopia Management
A parent-friendly guide to low-dose prescription eye drops that may help slow myopia progression in children.
30-80%
Effectiveness
4-16
Age Range
Nightly
One Drop
How Prescription Eye Drops Work
A medication-based approach to slowing eye growth
The Science
The exact mechanism is not fully understood, but these eye drops are believed to help slow abnormal eye growth associated with myopia progression. One commonly used medication in this category is low-dose atropine.
May help slow myopia progression
Easy to use (one drop at bedtime)
Can be combined with other treatments
Generally well tolerated at low doses
Simple Administration
Just one drop in each eye at bedtime. Takes less than a minute and becomes part of the nightly routine.
Combination Friendly
Can be used alongside myopia control glasses, orthokeratology, or myopia control contact lenses for enhanced effect in rapid progressors.
Customizable Dose
Doctors can adjust concentration based on your child's response and tolerance, from 0.01% to 0.05%.
Quick Facts
Nightly prescription eye drops
Often prescribed off-label; FDA approval pending for myopia use (NVK-002)
Goal
Help slow myopia progression
Typical use
Low-dose treatment over time, one drop per eye at bedtime
Monitoring
Regular follow-up visits with your eye care provider
Concentration Guide
Different concentrations offer varying levels of efficacy and side effects
← Scroll to see more →
| Concentration | Efficacy | Side Effects | Notes |
|---|---|---|---|
| 0.01% | 30-50% | Minimal | Most commonly prescribed; best balance of efficacy and tolerability |
| 0.025% | 40-55% | Low | Moderate option for children who need more effect |
| 0.05% | 50-65% | Moderate | Higher efficacy but more photophobia; may need photochromic lenses |
| 0.1%+ | 60-80% | Significant | Reserved for rapid progressors; requires careful monitoring |
Your eye care provider will recommend the appropriate concentration based on your child's myopia progression rate and tolerance.
Clinical Research
Decades of research support atropine's effectiveness in myopia control
Reduction in Myopia Progression
Depending on concentration used
Key Clinical Studies
Are Prescription Eye Drops Right for Your Child?
Prescription eye drops are a versatile option that works for many children, especially those who prefer drops over contact lenses or need a medication-based approach.
Ideal Candidates:
Age Range
4-16 years (varies by protocol)
Myopia Range
Any level of myopia
Administration
One drop per eye at bedtime
Combination
Can be used with glasses, contacts, or Ortho-K
Monitoring
Regular eye exams required
Considerations:
Often prescribed off-label
May cause mild light sensitivity
Mild pupil dilation is possible
May require a specialty or compounding pharmacy
Long-term effects are still being studied
Cost Breakdown
Understanding the investment in prescription eye drop treatment
Typical Annual Cost
$600 - $1,200
Note: Atropine must be obtained from a compounding pharmacy with a prescription. Most insurance plans do not cover compounded medications. FSA/HSA funds can typically be used.
* Cost estimates are representative ranges and vary by pharmacy, region, and concentration prescribed. Always confirm pricing with your prescribing doctor and compounding pharmacy.
Healthcare Financing Partner Wanted
Reach parents actively researching atropine treatment. Premium placement on high-intent pages with engaged audiences seeking financing solutions.
Key Research Sources
Peer-reviewed studies supporting this content
Atropine for the Treatment of Childhood Myopia (ATOM 2)
Ophthalmology
Low-dose atropine (0.01%) slows myopia progression by ~50% with minimal side effects.
Low-Concentration Atropine for Myopia Progression (LAMP)
Ophthalmology
0.05% atropine showed the best balance of efficacy and tolerability.
Combination of Orthokeratology and Atropine
Ophthalmology
Combining Ortho-K with 0.01% atropine provided better control than either alone.
Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial
JAMA
0.05% atropine reduced 2-year myopia incidence by 47% vs placebo in non-myopic children aged 4-9.
Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial
JAMA Ophthalmology
0.01% atropine did NOT significantly slow myopia progression in US children compared to placebo.
Frequently Asked Questions
Are prescription eye drops used for myopia management?
Yes. Low-dose prescription eye drops are used in myopia management and may help slow myopia progression in some children. One commonly used option is low-dose atropine, which has been studied in multiple clinical trials.
How are low-dose eye drops used?
They are typically applied once nightly — one drop per eye at bedtime. The routine is simple and takes less than a minute. Your eye doctor will recommend the appropriate concentration for your child.
What side effects should parents know about?
At low doses, most children tolerate these drops well. Some may experience mild light sensitivity or mild pupil dilation. Higher concentrations may cause more noticeable effects. Your doctor will monitor your child regularly.
Are prescription eye drops used alone or with other treatments?
They can be used alone or in combination with other myopia control options such as orthokeratology, myopia control contact lenses, or myopia control glasses — especially for children with faster progression.
How long does my child need to use prescription eye drops?
Treatment typically continues until myopia stabilizes, usually through the teenage years. Your doctor will monitor progression and adjust the treatment plan accordingly.
Other Medication-Based Options
Three pharmacological agents have demonstrated efficacy in reducing myopia progression in human clinical trials. Atropine is the most widely used, but pirenzepine and 7-methylxanthine offer alternatives for specific clinical scenarios.
| Agent | Mechanism | Efficacy | Regulatory Status | Availability |
|---|---|---|---|---|
| Low-Dose Atropine (0.01–0.05%)Most Used | Muscarinic antagonist; blocks M1/M4 receptors in the sclera | 30–80% reduction in progression | Off-label (FDA); approved in some Asian markets | Compounding pharmacies (US); commercial (Asia) |
| Pirenzepine 2% Gel | Selective M1 muscarinic antagonist | ~41% reduction over 2 years | Off-label; no longer commercially available in most markets | Limited; research/compounding only |
| 7-Methylxanthine (7-MX) | Adenosine receptor antagonist; stimulates scleral collagen cross-linking | ~25–30% reduction in axial elongation | Investigational; approved in Denmark for myopia control | Denmark (Myopinol); investigational elsewhere |
Pirenzepine 2% Gel
Selective M1 Muscarinic AntagonistPirenzepine was the first selective muscarinic antagonist studied specifically for myopia control. Two Phase 3 trials (US and Asia) demonstrated approximately 41% reduction in myopia progression over 2 years with twice-daily application. Unlike atropine, it has a more selective receptor profile, which was expected to reduce side effects — but it was never commercialized after its trials concluded.
7-Methylxanthine (7-MX)
Adenosine Receptor Antagonist — Oral Tablet7-Methylxanthine (sold as Myopinol in Denmark) is a metabolite of caffeine and theobromine. It works via a fundamentally different mechanism than atropine — it stimulates scleral collagen fibril thickening, making the eye more resistant to elongation. Clinical trials in Danish children showed a ~25–30% reduction in axial elongation. It is taken orally (400 mg/day), not as an eye drop.
Clinical Guidance
Of the three pharmacological agents, low-dose atropine (0.01–0.05%) remains the first-line choice in clinical practice due to its established evidence base, prescriber familiarity, and availability through compounding pharmacies. Pirenzepine and 7-MX are not currently accessible in most US practices. Discuss all options with a myopia management specialist.
Ready to Discuss Prescription Eye Drops?
Find an eye care professional who can discuss prescription eye drop options and schedule a consultation for your child.
Find Prescription Eye Drop Specialists by City
Connect with certified myopia control specialists offering prescription eye drop treatment in your area.
Key Research Citations
• Chua WH, et al. Atropine for the treatment of childhood myopia. Ophthalmology. 2006.
• Chia A, et al. ATOM2 Study: 0.5%, 0.1%, and 0.01% doses. Ophthalmology. 2012.
• Yam JC, et al. LAMP Study. Ophthalmology. 2019.
Compare Other Proven Myopia Treatment Options
Every child is different. Explore all evidence-based options.
Ortho-K
Custom lenses worn overnight reshape the cornea while your child sleeps. Clear vision all day — no glasses.
Learn about Ortho-KMyopia Contact Lenses
Soft daily contact lenses designed to slow myopia progression. Multiple FDA-approved brands available for children and teens.
Learn about Myopia Contact LensesMyopia Control Glasses
Specialized lenses like Stellest and MiYOSMART that slow progression — no contacts required.
Learn about Myopia Control GlassesWritten by
Editorial Team
Reviewed by
Our Medical Review Team
Last reviewed
February 2026
Worried your child's myopia (nearsightedness) is getting worse?
Take the 2–3 minute risk assessment and get a clear next step.
Eye doctor?
List your practice where parents search for myopia specialists.
Join thousands of listed providers nationwide.
5 Signs Your Child Needs Myopia Control
A quick-start guide for concerned parents. Learn when to take action.
Last reviewed: October 2, 2025